Colden Johanson

642 total citations · 1 hit paper
10 papers, 440 citations indexed

About

Colden Johanson is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, Colden Johanson has authored 10 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 2 papers in Genetics. Recurrent topics in Colden Johanson's work include Advanced Breast Cancer Therapies (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). Colden Johanson is often cited by papers focused on Advanced Breast Cancer Therapies (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). Colden Johanson collaborates with scholars based in United States, Netherlands and United Kingdom. Colden Johanson's co-authors include V. Paul Doria‐Rose, Chester Pabiniak, Sara Fischer, Karen M. Kuntz, Ann G. Zauber, Amy B. Knudsen, Carolyn M. Rutter, Iris Lansdorp‐Vogelaar, Steffie K. Naber and G. Scott Gazelle and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Cancer.

In The Last Decade

Colden Johanson

9 papers receiving 431 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies

2016 335 citations Amy B. Knudsen, Ann G. Zauber et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Colden Johanson United States	5	335	238	139	106	37	10	440
Louise Nott Australia	11	360 1.1×	161 0.7×	87 0.6×	87 0.8×	8 0.2×	65	456
Wilson Cheung Hong Kong	6	169 0.5×	93 0.4×	67 0.5×	171 1.6×	23 0.6×	9	403
Amanda C. R. K. Bos Netherlands	10	430 1.3×	158 0.7×	100 0.7×	200 1.9×	6 0.2×	16	563
Felicitas Lenz Germany	6	196 0.6×	161 0.7×	73 0.5×	135 1.3×	6 0.2×	8	421
Jeffrey T. Yorio United States	8	193 0.6×	136 0.6×	58 0.4×	70 0.7×	12 0.3×	22	323
Trine Frøslev Denmark	10	296 0.9×	170 0.7×	90 0.6×	67 0.6×	4 0.1×	15	375
Lesley‐Ann Miller‐Wilson United States	11	255 0.8×	135 0.6×	99 0.7×	51 0.5×	17 0.5×	33	310
Teeranut Boonpipattanapong Thailand	11	251 0.7×	93 0.4×	80 0.6×	152 1.4×	11 0.3×	18	409
Diana S.M. Buist United States	10	420 1.3×	89 0.4×	113 0.8×	178 1.7×	31 0.8×	15	708

Countries citing papers authored by Colden Johanson

Since Specialization

Citations

This map shows the geographic impact of Colden Johanson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colden Johanson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colden Johanson more than expected).

Fields of papers citing papers by Colden Johanson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colden Johanson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colden Johanson. The network helps show where Colden Johanson may publish in the future.

Co-authorship network of co-authors of Colden Johanson

This figure shows the co-authorship network connecting the top 25 collaborators of Colden Johanson. A scholar is included among the top collaborators of Colden Johanson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colden Johanson. Colden Johanson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Garcia‐Manero, Guillermo, Rayna K. Matsuno, Ali McBride, et al.. (2024). Clinical Outcomes and Healthcare Resource Utilization for Patients With Lower-Risk Myelodysplastic Syndromes Treated With Erythropoiesis-Stimulating Agents. Clinical Lymphoma Myeloma & Leukemia. 24(9). e283–e292.

Varghese, Della, et al.. (2024). A real-world study of treatment sequences and second-line clinical outcomes in patients with HER2-positive metastatic breast cancer in US community practice. International Journal of Clinical Oncology. 29(6). 780–789. 1 indexed citations

Varghese, Della, et al.. (2023). Abstract P1-11-19: A real-world evidence study of treatment patterns in patients with HER2-positive metastatic breast cancer who have received at least 2-lines of therapy. Cancer Research. 83(5_Supplement). P1–11. 1 indexed citations

Campbell, Alicyn, Colden Johanson, Elisabeth Piault, et al.. (2022). Epidemiology of interstitial lung disease in patients with metastatic breast cancer at baseline and after treatment with HER2-directed therapy: a real-world data analysis. Breast Cancer Research and Treatment. 196(3). 603–611. 4 indexed citations

Johanson, Colden, et al.. (2022). Machine learning application to find patients with lower-risk myelodysplastic syndrome from real-world data.. Journal of Clinical Oncology. 40(16_suppl). 1555–1555. 2 indexed citations

Izano, Monika A., et al.. (2022). Abstract 4089: Time to treatment discontinuation and time to next treatment as proxies of real-world progression-free survival in breast cancer patients. Cancer Research. 82(12_Supplement). 4089–4089. 5 indexed citations

Han, Summer S., Kevin ten Haaf, William D. Hazelton, et al.. (2017). The impact of overdiagnosis on the selection of efficient lung cancer screening strategies. International Journal of Cancer. 140(11). 2436–2443. 33 indexed citations

Knudsen, Amy B., Ann G. Zauber, Carolyn M. Rutter, et al.. (2016). Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies. JAMA. 315(23). 2595–2595. 335 indexed citations breakdown →

Lowry, Kathryn P., G. Scott Gazelle, Colden Johanson, et al.. (2015). Personalizing annual lung cancer screening for patients with chronic obstructive pulmonary disease: A decision analysis. Cancer. 121(10). 1556–1562. 21 indexed citations

10.

Lubitz, Carrie C., Konstantinos P. Economopoulos, Stephen Sy, et al.. (2015). Cost-Effectiveness of Screening for Primary Aldosteronism and Subtype Diagnosis in the Resistant Hypertensive Patients. Circulation Cardiovascular Quality and Outcomes. 8(6). 621–630. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact